metoclopramide + ibuprofen

Metoclopramide + ibuprofen is a combination of two small molecule drugs formulated for the treatment of acute migraine. Metoclopramide is a dopamine D2 receptor antagonist with antiemetic and prokinetic properties, commonly used to treat nausea, vomiting, and gastroparesis by increasing gastric motility. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that acts as a non-selective cyclooxygenase (COX-1 and COX-2) inhibitor to reduce pain, inflammation, and fever. The rationale for combining these agents in a bi-layer tablet is that metoclopramide enhances the absorption of acidic NSAIDs like ibuprofen by accelerating gastric emptying while also addressing migraine-associated nausea; meanwhile, separating their release prevents degradation of metoclopramide from prolonged contact with the acidic NSAID[1][3]. This combination aims to maximize efficacy in acute migraine management.